[go: up one dir, main page]

TN2009000329A1 - DERIVES DE 2-AMINO-5,7-DIHYDRO-6H-PYRROLO[3,4-d]-PYRIMIDINE SERVANT D'INHBITEURS DE HSP-90 POUR LE TRAITEMENT DU CANCER - Google Patents

DERIVES DE 2-AMINO-5,7-DIHYDRO-6H-PYRROLO[3,4-d]-PYRIMIDINE SERVANT D'INHBITEURS DE HSP-90 POUR LE TRAITEMENT DU CANCER

Info

Publication number
TN2009000329A1
TN2009000329A1 TNP2009000329A TN2009000329A TN2009000329A1 TN 2009000329 A1 TN2009000329 A1 TN 2009000329A1 TN P2009000329 A TNP2009000329 A TN P2009000329A TN 2009000329 A TN2009000329 A TN 2009000329A TN 2009000329 A1 TN2009000329 A1 TN 2009000329A1
Authority
TN
Tunisia
Prior art keywords
hsp
inhbitors
pyrrolo
dihydro
cancer
Prior art date
Application number
TNP2009000329A
Other languages
English (en)
Inventor
Michael John Bennett
Luke Raymond Zehnder
Sacha Ninkovic
Pei-Pei Kung
Jerry Jialun Meng
Buwen Huang
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of TN2009000329A1 publication Critical patent/TN2009000329A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La présente invention concerne des composés de formule (I) : et leurs sels parmaceutiquement acceptables, leur synthèse, et leur utilisation comme inhibiteurs de HSP-90.
TNP2009000329A 2007-02-06 2009-08-04 DERIVES DE 2-AMINO-5,7-DIHYDRO-6H-PYRROLO[3,4-d]-PYRIMIDINE SERVANT D'INHBITEURS DE HSP-90 POUR LE TRAITEMENT DU CANCER TN2009000329A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88843307P 2007-02-06 2007-02-06
US2066108P 2008-01-11 2008-01-11
PCT/IB2008/000200 WO2008096218A1 (fr) 2007-02-06 2008-01-25 Dérivés de 2-amino-5,7-dihydro-6h-pyrrolo[3,4-d]pyrimidine en tant qu'inhibiteurs de la hsp 90 pour le traitement du cancer

Publications (1)

Publication Number Publication Date
TN2009000329A1 true TN2009000329A1 (fr) 2010-12-31

Family

ID=39367692

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2009000329A TN2009000329A1 (fr) 2007-02-06 2009-08-04 DERIVES DE 2-AMINO-5,7-DIHYDRO-6H-PYRROLO[3,4-d]-PYRIMIDINE SERVANT D'INHBITEURS DE HSP-90 POUR LE TRAITEMENT DU CANCER

Country Status (22)

Country Link
US (1) US20100093696A1 (fr)
EP (1) EP2118111B1 (fr)
JP (1) JP4523073B2 (fr)
KR (1) KR20090116789A (fr)
AP (1) AP2009004954A0 (fr)
AT (1) ATE502944T1 (fr)
AU (1) AU2008212645A1 (fr)
BR (1) BRPI0807165A2 (fr)
CA (1) CA2677365A1 (fr)
CO (1) CO6220971A2 (fr)
CR (1) CR10963A (fr)
CU (1) CU20090141A7 (fr)
DE (1) DE602008005715D1 (fr)
DO (1) DOP2009000200A (fr)
EA (1) EA200970669A1 (fr)
EC (1) ECSP099565A (fr)
IL (1) IL200169A0 (fr)
MA (1) MA31170B1 (fr)
MX (1) MX2009008386A (fr)
NI (1) NI200900155A (fr)
TN (1) TN2009000329A1 (fr)
WO (1) WO2008096218A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2732922A1 (fr) 2008-08-13 2010-02-18 Pfizer Inc. Composes 2-amino pyrimidine comme inhibiteurs puissants de l'hsp-90
GB0907284D0 (en) 2009-04-28 2009-06-10 Queen Mary & Westfield College Compounds for inducing cellular apoptosis
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
CN102822169A (zh) 2009-12-30 2012-12-12 艾科尔公司 取代的萘基-嘧啶化合物
EP2752201A1 (fr) * 2013-01-04 2014-07-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Inhibiteurs de HSP90 C-terminal pour traiter les adénomes hypophysaires
AR095036A1 (es) 2013-03-14 2015-09-16 Kalyra Pharmaceuticals Inc Compuestos analgésicos bicíclicos
JP6542794B2 (ja) 2013-12-12 2019-07-10 ゼノ ロイアルティー アンド マイルストーンズ リミテッド ライアビリティー カンパニー 二環式アルキル化合物、および合成
EP3114107B1 (fr) 2014-03-07 2020-07-22 Recurium IP Holdings, LLC Dérivés de propellane et synthèse
ES2954453T3 (es) 2014-06-13 2023-11-22 Yuma Therapeutics Inc Compuestos de pirimidina y métodos que utilizan los mismos
EP3193855B1 (fr) 2014-09-17 2021-05-19 Recurium IP Holdings, LLC Composés bicycliques
US10227029B2 (en) * 2015-08-07 2019-03-12 Kawasaki Jukogyo Kabushiki Kaisha Container holder attached to utility vehicle
BR112019024155A2 (pt) 2017-05-15 2020-06-02 Recurium Ip Holdings, Llc Compostos analgésicos
WO2020243457A1 (fr) * 2019-05-29 2020-12-03 Viogen Biosciences, Llc Composés et leurs utilisations thérapeutiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
BRPI0108394B8 (pt) 2000-02-15 2021-05-25 Upjohn Co inibidores de proteína de quinase de 2-indolinona de pirrol substituído, seus sais e composições farmacêuticas compreendendo os mesmos
WO2003062225A1 (fr) * 2002-01-23 2003-07-31 Bayer Pharmaceuticals Corporation Derives pyrimidine en tant qu'inhibiteurs de kinase rho
US7312330B2 (en) * 2003-12-24 2007-12-25 Renovis, Inc. Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
AU2006230447A1 (en) * 2005-03-30 2006-10-05 Conforma Therapeutics Corporation Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors

Also Published As

Publication number Publication date
BRPI0807165A2 (pt) 2014-05-06
WO2008096218A1 (fr) 2008-08-14
CO6220971A2 (es) 2010-11-19
IL200169A0 (en) 2010-04-15
NI200900155A (es) 2010-06-30
CR10963A (es) 2009-08-27
EA200970669A1 (ru) 2010-02-26
JP4523073B2 (ja) 2010-08-11
JP2010518066A (ja) 2010-05-27
MA31170B1 (fr) 2010-02-01
AU2008212645A1 (en) 2008-08-14
DE602008005715D1 (de) 2011-05-05
AP2009004954A0 (en) 2009-08-31
CA2677365A1 (fr) 2008-08-14
MX2009008386A (es) 2009-10-16
US20100093696A1 (en) 2010-04-15
EP2118111A1 (fr) 2009-11-18
CU20090141A7 (es) 2011-04-26
KR20090116789A (ko) 2009-11-11
EP2118111B1 (fr) 2011-03-23
ECSP099565A (es) 2009-09-29
ATE502944T1 (de) 2011-04-15
DOP2009000200A (es) 2009-09-15

Similar Documents

Publication Publication Date Title
TN2009000329A1 (fr) DERIVES DE 2-AMINO-5,7-DIHYDRO-6H-PYRROLO[3,4-d]-PYRIMIDINE SERVANT D'INHBITEURS DE HSP-90 POUR LE TRAITEMENT DU CANCER
TN2010000052A1 (fr) Derives de pyrazole et leur utilisation comme inhibiteurs de raf
TN2009000085A1 (fr) Derives de pyrido (2,3-d) pyrimidinone et leur utilisation comme inhibiteurs de pi3
GEP20156282B (en) Compounds and compositions as protein kinase inhibitors
MY141220A (en) Pyrazole derivatives as inhibitors of receptor tyrosine kinases
NO2016021I1 (no) 5-amino-2,4,7-triokso-3,4,7,8-tetrahydro-2Hpyrido[2,3-D]pyrimidinderivater og relaterte forbindelser for behandling av kreft
EA200900152A1 (ru) Ингибиторы пирролотриазинкиназы
DK1678166T3 (da) Proteinkinaseinhibitorer
MA33670B1 (fr) Derives de pyrrolo[2,3-d]pyrimidine
SG178591A1 (en) Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer
MA31419B1 (fr) Derives de pyridine
EA201001017A1 (ru) 3h-[1,2,3]триазоло[4,5-d]пиримидиновые соединения, их применение в качестве ингибиторов киназы mtor и киназы pi3 и их синтезы
MA32135B1 (fr) Inhibiteurs de pim kinase et leurs procedes d'utilisation
MA31903B1 (fr) Derives de thiazole utilises comme inhibiteur de la pi 3 kinase
TNSN08283A1 (en) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
MX2008005398A (es) Derivados de 4-(3-amino-pirazol)-pirimidina para uso como inhibidores de tirosina cinasa en el tratamiento de cancer.
GB0112348D0 (en) Compounds
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
EA201000552A1 (ru) Производные пирроло[2,3-d]пиримидина в качестве ингибиторов протеинкиназы в
EA200600973A1 (ru) ПИРИДО[2,3-d] ПИРИМИДИН-2,4-ДИАМИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ PDE 2
EA200970936A1 (ru) СОЕДИНЕНИЯ ПИРИДО[2,3-d]ПИРИМИДИН-7-ОНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3K-АЛЬФА ДЛЯ ЛЕЧЕНИЯ РАКА
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
MX2010013682A (es) Derivados de 2,4-diamino-l,3,5-triazina triciclicos utiles para el tratamiento del cancer y trastornos mieloproliferativos.
TNSN08020A1 (en) 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
MX2012002327A (es) Inhibidores de cinasa, formas de profarmaco de los mismos y su uso en terapia.